Biolase, Inc.
BIOL
BIOL was delisted on the 18th of June, 2024.
34 hedge funds and large institutions have $48.1M invested in Biolase, Inc. in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 7 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
6% less funds holding
Funds holding: 36 → 34 (-2)
10% less capital invested
Capital invested by funds: $53.8M → $48.1M (-$5.63M)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
+$2.78M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$1.29M |
| 3 |
VAM
Visium Asset Management
New York
|
+$512K |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
+$146K |
| 5 |
QSS
Quantitative Systematic Strategies
Ponte Vedra Beach,
Florida
|
+$122K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$4M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
-$1.39M |
| 3 |
RA
Royce & Associates
New York
|
-$336K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$235K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$146K |
BIOL Hedge Fund Activity: Q2 2015 in Review
34 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q2 2015, worth a combined $48.1M — down 10% from $53.8M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of BIOL and 5 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 8 added.
The largest buyer was Boston Partners, opening a new position worth an estimated $2.78M. The largest seller was Camber Capital Management, cutting an estimated $4M.
- 34 institutional investors held Biolase, Inc. (BIOL) as of Q2 2015, down from 36 in Q1 2015.
- Funds reported $48.1M of Biolase, Inc. stock for Q2 2015, down 10% quarter-over-quarter.
- 5 funds opened new Biolase, Inc. positions in Q2 2015 and 7 closed out, a net change of -2 holders.
- The largest Biolase, Inc. buyer in Q2 2015 was Boston Partners, an estimated $2.78M added.
- The largest Biolase, Inc. seller in Q2 2015 was Camber Capital Management, an estimated $4M sold.
Based on aggregated 13F filings for Q2 2015.